Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,821 | 85,798 | 71,599 | 84,987 | 104,073 |
| Marketable Securities | 121,641 | 126,360 | 281,996 | 272,031 | 268,243 |
| Receivables | 85,067 | 85,904 | 87,600 | 88,032 | 97,706 |
| Inventories | 23,919 | 18,906 | N/A | N/A | 5,007 |
| Income taxes - deferred | 6,445 | 6,529 | 9,074 | 8,768 | 8,007 |
| TOTAL | $322,423 | $338,164 | $454,506 | $458,675 | $483,992 |
| Non-Current Assets | |||||
| PPE Net | 34,594 | 32,665 | 31,313 | 30,675 | 27,602 |
| Investments And Advances | 84,124 | 65,555 | 135,187 | 158,566 | 158,748 |
| Intangibles | 374,493 | 375,042 | 69,692 | 69,936 | 70,180 |
| Other Non-Current Assets | 8,180 | 5,000 | 65,983 | 63,806 | 63,299 |
| TOTAL | $501,391 | $478,262 | $302,175 | $322,983 | $319,829 |
| Total Assets | $823,814 | $816,426 | $756,681 | $781,658 | $803,821 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,078 | 18,935 | 17,596 | 18,745 | 18,132 |
| Accrued Expenses | 56,410 | 51,103 | 45,844 | 59,390 | 44,334 |
| TOTAL | $80,578 | $72,156 | $67,392 | $79,030 | $64,509 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,090 | 2,118 | 3,952 | 895 | 2,043 |
| Other Non-Current Liabilities | 24,238 | 13,641 | 13,318 | 12,356 | 10,718 |
| TOTAL | $24,238 | $22,028 | $13,318 | $12,356 | $10,718 |
| Total Liabilities | $104,816 | $94,184 | $80,710 | $91,386 | $75,227 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 74,824 | 72,974 | 74,753 | N/A |
| Common Shares | 735 | 745 | 740 | 768 | 806 |
| Retained earnings | 2,004 | 18,865 | 11,603 | 13,955 | 30,866 |
| Other shareholders' equity | -1,515 | -122 | 506 | 365 | -424 |
| TOTAL | $718,998 | $722,242 | $675,971 | $690,272 | $728,594 |
| Total Liabilities And Equity | $823,814 | $816,426 | $756,681 | $781,658 | $803,821 |